The Valley Desk

NCT00263692 · Interventional trial

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety

Overall registry status Completed

Phase 2

Conditions Acellular Pertussis, Diphtheria, Tetanus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov